Gary Hattersley - 20 Nov 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Stephen Dang, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
20 Nov 2025
Net transactions value
-$1,964,983
Form type
4
Filing time
24 Nov 2025, 16:09:42 UTC
Previous filing
29 Oct 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hattersley Gary CHIEF SCIENTIFIC OFFICER C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK /s/ Stephen Dang, Attorney-in-Fact 24 Nov 2025 0001521111

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVB Class A Common Stock Options Exercise $120,149 +69,051 $1.74 69,051 20 Nov 2025 Direct
transaction NUVB Class A Common Stock Sale $499,032 -69,051 -100% $7.23 0 20 Nov 2025 Direct F1
transaction NUVB Class A Common Stock Options Exercise $582,000 +300,000 $1.94 300,000 20 Nov 2025 Direct
transaction NUVB Class A Common Stock Sale $2,168,100 -300,000 -100% $7.23 0 20 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Options Exercise $0 -69,051 -23% $0.000000 229,884 20 Nov 2025 Class A Common Stock 69,051 $1.74 Direct F2
transaction NUVB Stock Option (Right to Buy) Options Exercise $0 -300,000 -60% $0.000000 200,000 20 Nov 2025 Class A Common Stock 300,000 $1.94 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2 Options vested as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years.
F3 Options vested as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.